Symptomatic Botulism
Drug | Drug Name | Drug Description |
---|---|---|
DB13900 | Equine Botulinum Neurotoxin A Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13903 | Equine Botulinum Neurotoxin B Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13898 | Equine Botulinum Neurotoxin C Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13902 | Equine Botulinum Neurotoxin D Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13897 | Equine Botulinum Neurotoxin E Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13901 | Equine Botulinum Neurotoxin F Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
DB13899 | Equine Botulinum Neurotoxin G Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
Drug | Drug Name | Phase | Status | Count |
---|